查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1987966

劑量監測設備市場：按類型、技術、應用、最終用戶和分銷管道分類－2026-2032年全球市場預測

Dose Monitoring Device Market by Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，劑量監測設備市場價值將達到 39.3 億美元，到 2026 年將成長至 42.8 億美元，到 2032 年將達到 73.2 億美元，複合年成長率為 9.29%。

主要市場統計數據
基準年 2025 39.3億美元
預計年份：2026年 42.8億美元
預測年份 2032 73.2億美元
複合年成長率 (%) 9.29%

這是一本針對醫療保健決策者的劑量監測設備重要指南，系統地說明了其臨床意義、技術前景和策略考量。

劑量監測設備是臨床安全、數位醫療創新和個人化患者照護的關鍵所在。這些系統種類繁多，從整合到臨床工作流程中的簡單、非穿戴式劑量追蹤器，到能夠持續記錄給藥事件並透過無線通訊協定傳輸資料的先進穿戴式平台，應有盡有。隨著醫療保健系統將藥物依從性、減少可預防的不利事件和遠端病患管理置於優先地位，劑量監測設備正從小眾工具發展成為實現互聯互通的醫療路徑的關鍵基礎。

感測器技術的創新、對互通性的需求以及護理模式的轉變，都在共同作用，促使人們重新思考藥物監測設備的產品設計和市場進入策略。

藥物監測設備的市場格局正在經歷一場變革，這場變革是由技術、臨床和營運等多面向因素共同推動的。感測器小型化和低功耗無線通訊技術的進步，使得穿戴式裝置得以開發，從而能夠隱密地追蹤用藥情況。同時，物聯網基礎設施的改進，也促進了近乎即時的資料流向醫療管理平台。這些技術基礎正在降低使用門檻，並提高患者持續參與的可能性。

2025 年關稅變化和貿易結構調整將如何對藥物監測設備整個價值鏈的策略採購、在地化選擇和韌性規劃構成挑戰？

2025年計畫進行的關稅和貿易政策調整將為整個藥物監測設備生態系統的供應鏈和採購決策帶來更多戰略層面的影響。傳統上依賴跨境零件採購和契約製造的製造商需要重新評估供應商多元化、庫存策略以及潛在的在岸和近岸生產機會，以降低成本波動並維持供應的連續性。這些變更可能會影響前置作業時間、零件選擇和供應商認證流程。

以細分市場為中心的洞察揭示了類型、應用、技術、最終用戶環境和分銷選項如何決定部署路徑和產品優先順序。

為了解產品和市場動態，必須清楚掌握設備按外形規格、臨床應用、底層技術、終端用戶環境和通路進行分類的方式。按類型分類，市場分為非穿戴式裝置和穿戴式裝置兩大類，每類設備都體現了不同的設計限制和應用情境。非穿戴式系統優先考慮與臨床基礎設施的整合和穩定性，而穿戴式解決方案則強調舒適性、電池效率和持續性資料收集。按應用分類，市場涵蓋心血管護理、糖尿病管理和腫瘤學領域。每個應用領域都有其獨特的臨床工作流程、用藥依從性挑戰和監管要求，這些都會影響感測器選擇和資料模型。

醫療保健系統、法規和基礎設施的區域差異如何影響劑量監測解決方案的部署策略和營運重點？

區域趨勢受關鍵區域醫療保健系統結構、法律規範和部署模式差異的影響。美洲的醫療保健格局複雜，其特點是整合的醫療保健系統、以支付主導的價值評估，以及對遠端患者監護解決方案的強勁需求，以支持慢性病管理。在該地區運作的相關人員必須使臨床證據和報銷策略與不同相關人員的期望和支付系統相協調。歐洲、中東和非洲（EMEA）地區則呈現出監管嚴格和各國市場基礎設施​​成熟度不一的局面。雖然互通性和資料保護是成熟的歐洲醫療保健系統的首要關注點，但中東和非洲的一些市場則優先考慮擴充性、經濟高效的解決方案和夥伴關係關係，以加速在資源受限環境中的部署。

醫療設備製造商與技術供應商之間的企業策略、合作關係和服務創新正在塑造競爭差異化和夥伴關係的機會。

企業級趨勢的特點是產品創新、平台整合、策略夥伴關係以及不斷發展的服務交付模式的融合。成熟的醫療設備製造商正利用其在監管方面的專業知識和快速上市管道，將其產品組合擴展到劑量監測領域，通常會整合分析和雲端服務，為醫療服務提供者建立捆綁式解決方案。同時，科技主導的新興參與企業正透過用戶體驗、快速的產品改進和平台擴充性來脫穎而出，專注於無縫的行動連接和以消費者為中心的設計，以促進居家醫療環境中的用戶參與。

為高階主管提供切實可行的策略措施，以增強韌性、加速推廣並在劑量監測設備市場中獲得差異化價值。

產業領導者應採取一系列切實可行的措施，以平衡短期韌性與長期差異化。首先，應優先考慮互通性和基於標準的整合，使設備能夠連接到各種電子健康記錄環境和分析平台。這將減輕醫療專業人員的部署負擔，並增強支援長期照護解決方案的吸引力。

採用透明、以證據為基礎的調查方法，結合實務工作者訪談、標準審查和技術比較分析，為合理的決策提供支援。

本研究途徑整合了來自一手和二手資料的證據，旨在產生可操作的洞見，同時確保透明度和可重複性。主要輸入包括對臨床醫生、採購經理、技術整合商和供應鏈專家的結構化訪談，並輔以診所、醫院和居家照護機構的案例研究。這些定性觀點為工作流程整合、可用性挑戰和實施障礙提供了背景資訊——而這些資訊僅靠定量數據可能無法捕捉。

策略挑戰的整合，展示了技術、臨床證據和營運韌性的整合如何決定劑量監測的長期成功。

劑量監測設備正處於策略轉折點，技術能力、臨床需求和實際操作性在此交匯融合。其部署的最終結果將取決於製造商和服務供應商能否將感測器和連接方面的創新轉化為檢驗、可互通的解決方案，以適應現有的臨床工作流程並支援遠距醫療。監管政策的明確、支付方的參與以及臨床療效的證據將推動其應用，而不斷變化的收費系統和日益複雜的供應鏈將考驗企業的韌性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 劑量監測設備市場：依類型分類

  • 不穿戴式
  • 穿戴式裝置

第9章 劑量監測設備市場：依技術分類

  • Bluetooth
  • 基於物聯網
  • NFC
  • RFID

第10章：劑量監測設備市場：依應用領域分類

  • 循環系統護理
  • 糖尿病管理
  • 癌症治療

第11章 劑量監測設備市場：依最終用戶分類

  • 診所
  • 居家醫療
  • 醫院

第12章 劑量監測設備市場：依通路分類

  • 離線頻道
    • 直銷
    • 銷售代理
  • 線上管道
    • EC平台
    • 製造商網站

第13章 劑量監測設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 劑量監測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 劑量監測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國劑量監測設備市場

第17章：中國劑量監測設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bayer AG
  • Bracco SpA
  • Canon Inc.
  • Dozee
  • Fluke Corporation
  • Fuji Electric Co., Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guerbet
  • IBA Dosimetry GmbH
  • Infab Corporation
  • INFINITT Healthcare Co., Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Landauer, Inc.
  • LANDAUER, Inc. by Fortive Corporation
  • Medic Vision
  • Medsquare
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • PTW-Freiburg GmbH
  • QAELUM NV
  • Radcal Corporation
  • Radiation Monitoring Devices, Inc.
  • RADOS Technology Oy
  • RaySafe by Fluke Corporation
  • Sectra AB
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Unfors RaySafe AB
  • Victoreen, LLC
  • Volpara Health Limited
Product Code: MRR-A413C23B631F

The Dose Monitoring Device Market was valued at USD 3.93 billion in 2025 and is projected to grow to USD 4.28 billion in 2026, with a CAGR of 9.29%, reaching USD 7.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.93 billion
Estimated Year [2026] USD 4.28 billion
Forecast Year [2032] USD 7.32 billion
CAGR (%) 9.29%

An essential introduction to dose monitoring devices that frames clinical relevance, technological expectations, and strategic considerations for healthcare decision-makers

Dose monitoring devices sit at the intersection of clinical safety, digital health innovation, and individualized patient care. These systems range from simple non-wearable dose trackers integrated into clinical workflows to advanced wearable platforms that continuously log administration events and transmit data through wireless protocols. As healthcare systems emphasize medication adherence, reduction of preventable adverse events, and remote patient management, dose monitoring devices have evolved from niche tools into critical enablers of coordinated care pathways.

Clinicians and healthcare administrators now expect solutions that not only record dosing events but also integrate seamlessly with electronic health records, support interoperability standards, and enable analytics for population health management. At the same time, consumer-facing expectations are shaping device design: usability, unobtrusiveness, and secure connectivity are central to adoption in homecare settings. Regulatory scrutiny and reimbursement dynamics further drive product development, compelling manufacturers to demonstrate safety, privacy controls, and clinical value in rigorous settings.

Consequently, investment in dose monitoring must balance technical innovation with human-centered design and evidence generation. Decision-makers should consider how devices will function across point-of-care environments, how they will integrate with clinical workflows, and how data governance frameworks will ensure patient privacy and regulatory compliance. The following sections unpack the transformative shifts, tariff-related headwinds, segmentation dynamics, regional behavior, company-level developments, and actionable recommendations that stakeholders should weigh as they design their next moves in this evolving domain.

The confluence of sensor innovation, interoperability demands, and care model transformation reshaping product design and go-to-market strategies for dose monitoring devices

The landscape for dose monitoring devices is undergoing a phase of transformative change driven by converging technological, clinical, and operational forces. Advances in sensor miniaturization and low-power wireless communications have enabled the development of wearables that can unobtrusively track dosing events, while improvements in IoT infrastructure facilitate near-real-time data flows into care management platforms. These technical enablers reduce friction at the point of use and increase the likelihood of sustained patient engagement.

Simultaneously, clinical paradigms are shifting toward value-based care models that prioritize outcomes and adherence metrics. This shift compels providers and payers to view dose monitoring not as an isolated device but as part of an ecosystem that links adherence data to clinical decision support, remote monitoring programs, and quality measurement. As a result, interoperability and standards alignment are emerging as non-negotiable design requirements, prompting manufacturers to invest in secure APIs, standardized data models, and compatibility with major electronic health record systems.

Operationally, distribution and service models are being reimagined. The growing expectation for patient-centric services accelerates demand for home-deployable systems and direct-to-consumer channels, while clinical settings favor robust, validated non-wearable solutions that integrate with existing workflows. In parallel, partnerships between device makers, software platform vendors, and clinical service providers are becoming essential to deliver end-to-end solutions that can demonstrate measurable clinical impact. Taken together, these trends are recalibrating product roadmaps, go-to-market strategies, and investment priorities across the ecosystem.

How tariff changes and trade realignments in 2025 compel strategic sourcing, localization choices, and resilience planning across the dose monitoring device value chain

Tariffs and trade policy adjustments scheduled for 2025 introduce an additional strategic dimension for supply chain and sourcing decisions across the dose monitoring device ecosystem. Manufacturers that have historically relied on cross-border component sourcing and contract manufacturing must reassess supplier diversification, inventory strategies, and potential onshoring or nearshoring opportunities to mitigate cost volatility and maintain continuity of supply. These shifts can influence lead times, component selection, and supplier qualification processes.

Beyond pure cost considerations, tariffs affect strategic choices about where to perform value-added activities such as assembly, final testing, and software localization. Firms may decide to relocate certain manufacturing steps closer to primary end markets to reduce exposure, improve responsiveness to regulatory changes, or take advantage of regional incentives. In doing so, they must weigh the operational implications for quality control, intellectual property protection, and access to skilled labor.

Importers and distributors also face operational implications as duty changes alter landed costs and pricing strategies. To preserve margins and market competitiveness, many organizations will explore contractual hedging, long-term supplier agreements, or adjustments to channel strategies. For stakeholders engaging with global partners, proactive scenario planning and a clear communication plan for customers and clinicians will help preserve trust and reduce the risk of service disruption. Ultimately, tariffs in 2025 are prompting a reassessment of resilience, cost management, and strategic localization across the value chain.

Segment-focused insights illuminating how type, application, technology, end-user environment, and distribution choices dictate adoption pathways and product priorities

Understanding product and market dynamics requires a clear view of how devices are segmented by form factor, clinical use, enabling technologies, end-user settings, and distribution pathways. Based on type, the market is studied across non wearable and wearable devices, reflecting distinct design constraints and use cases; non wearable systems prioritize integration with clinical infrastructure and robustness, while wearable solutions emphasize comfort, battery efficiency, and continuous data capture. Based on application, the market is studied across cardiovascular care, diabetes management, and oncology treatment, each application area presenting unique clinical workflows, adherence challenges, and regulatory requirements that influence sensor choice and data models.

Based on technology, the market is studied across Bluetooth, IoT based architectures, NFC, and RFID, which define connectivity, range, and power profiles that determine deployment scenarios; Bluetooth often underpins consumer wearables and short-range device-to-mobile interactions, IoT based approaches support persistent cloud connectivity for remote monitoring, NFC facilitates close-proximity secure exchanges, and RFID enables passive tracking in many clinical environments. Based on end user, the market is studied across clinics, homecare settings, and hospitals, underscoring distinct operational priorities: clinics often focus on episodic interventions and rapid workflows, homecare emphasizes user experience and remote support, and hospitals demand validated integration with enterprise systems and scalable device management.

Based on distribution channel, the market is studied across offline channels and online channels. The offline channels are further studied across direct sales and distributors, reflecting traditional procurement pathways that emphasize service, installation, and institutional contracting. The online channels are further studied across e-commerce platforms and manufacturer websites, which support faster consumer access, digital marketing, and streamlined replenishment. Taken together, these segmentation lenses reveal how product design, pricing, clinical evidence generation, and go-to-market approaches must be aligned to the specific requirements of each segment to drive adoption and sustainable value.

How geographic differences in healthcare systems, regulation, and infrastructure shape adoption strategies and operational priorities for dose monitoring solutions

Regional dynamics are driven by differing healthcare system architectures, regulatory frameworks, and adoption patterns across major geographies. Americas often present a complex landscape shaped by integrated health systems, payer-driven value assessment, and a strong appetite for remote patient monitoring solutions that support chronic disease management; stakeholders operating in this region must align clinical evidence and reimbursement strategies with heterogeneous stakeholder expectations and payer systems. Europe, Middle East & Africa combine regulatory rigor with variable infrastructure maturity across national markets; in mature European healthcare systems, interoperability and data protection are primary concerns, while certain markets in the Middle East & Africa prioritize scalable, cost-effective solutions and partnerships that can accelerate deployment in resource-constrained settings.

Asia-Pacific exhibits broad heterogeneity, with markets ranging from highly tech-forward ecosystems embracing consumer wearables and mobile-first care delivery to regions prioritizing scalable, low-cost devices for wide population reach. Regional supplier networks and manufacturing ecosystems in Asia-Pacific also play an influential role, offering opportunities for cost-effective component sourcing and rapid iterative development. Across all regions, regulatory alignment, local clinical validation, and culturally appropriate user experience design remain decisive factors in determining uptake. Consequently, successful regional strategies blend global product standards with localized implementation plans that address reimbursement, clinical workflow integration, and end-user training.

Corporate strategies, alliances, and service innovations among device makers and technology providers shaping competitive differentiation and partnership opportunities

Company-level dynamics are characterized by a mix of product innovation, platform integration, strategic partnerships, and evolving service offerings. Established medical device firms are leveraging their regulatory expertise and go-to-market channels to extend portfolios into dose monitoring, often embedding analytics and cloud services to create bundled solutions for providers. At the same time, technology-first entrants are differentiating on user experience, rapid product iteration, and platform extensibility, focusing on seamless mobile integration and consumer-grade design to drive engagement in homecare contexts.

Collaborations between device manufacturers, healthcare IT vendors, and clinical service providers are increasingly common, enabling integrated offerings that bridge device telemetry with care management workflows and analytics. Strategic partnerships also facilitate faster route-to-market through distribution agreements, while co-development arrangements help align clinical validation efforts with practitioner needs. In parallel, service expansions that include training, managed monitoring, and outcome reporting are emerging as competitive differentiators, shifting commercial conversations from product sale to value-based service delivery.

For corporate investors and corporate development teams, potential pathways include targeted acquisitions to secure niche capabilities, licensing arrangements for key connectivity technologies, and multi-stakeholder pilots that validate clinical and operational impact. Firms that prioritize interoperability, data security, and a clear value proposition for providers and payers will be better positioned to capture demand as health systems increasingly prioritize adherence and medication safety initiatives.

Practical strategic moves for executives to strengthen resilience, accelerate adoption, and capture differentiated value in dose monitoring device markets

Industry leaders should adopt a set of pragmatic actions that balance near-term resilience with long-term differentiation. First, prioritize interoperability and standards-based integration to ensure devices can plug into diverse electronic health record environments and analytics platforms; this reduces implementation friction for healthcare customers and enhances the appeal of solutions that support longitudinal care.

Second, diversify sourcing and manufacturing footprints to mitigate tariff exposure and supply chain interruptions, while maintaining rigorous quality controls and clear traceability for critical components. Third, invest in clinical validation and outcomes research that demonstrates measurable improvements in adherence, safety, or workflow efficiency; robust evidence will facilitate payer discussions and institutional procurement. Fourth, design products with contextualized user experiences that reflect the needs of homecare patients and frontline clinicians alike, incorporating user-centered design practices and continuous feedback mechanisms to drive iterative improvements.

Finally, develop flexible commercial models that combine device sales with service-based offerings such as managed monitoring, clinician-facing dashboards, and outcome reporting. Such models align incentives across stakeholders and create recurring revenue pathways. Executives should sequence these moves with clear milestones, ensuring that technology investments, regulatory planning, and partnership negotiations progress in parallel to deliver both resilience and differentiated value.

A transparent, evidence-based research methodology integrating practitioner interviews, standards review, and comparative technology analysis to support sound decision-making

The research approach synthesizes evidence from primary and secondary sources to produce actionable insights while ensuring transparency and reproducibility. Primary inputs include structured interviews with clinicians, procurement leaders, technology integrators, and supply chain experts, supplemented by case studies of deployments across clinics, hospitals, and homecare settings. These qualitative perspectives provide context on workflow integration, usability challenges, and deployment barriers that quantitative data alone cannot capture.

Secondary inputs involve a systematic review of regulatory guidance, standards documentation, technology white papers, and peer-reviewed clinical studies relevant to dose monitoring technologies. Special attention is given to interoperability standards, data protection frameworks, and clinical outcome studies that assess device usability and impact. Comparative analysis techniques are applied to examine technology trade-offs-such as connectivity protocols and power management strategies-and to map product features to end-user requirements. Throughout the process, methodological safeguards, including triangulation of sources and explicit documentation of assumptions, are employed to maintain analytical rigor and to support confident decision-making by stakeholders.

Synthesis of strategic imperatives showing how integration of technology, clinical evidence, and operational resilience will determine long-term success in dose monitoring

Dose monitoring devices sit at a strategic inflection point where technological capability, clinical necessity, and operational pragmatism converge. The trajectory for adoption will be shaped by how well manufacturers and service providers can translate sensor and connectivity innovations into validated, interoperable solutions that fit existing clinical workflows and support remote care. Regulatory clarity, payer alignment, and evidence of clinical impact will serve as accelerants, while tariff shifts and supply chain complexity will test organizational resilience.

Stakeholders that prioritize user-centered design, invest in clinical validation, and cultivate partnerships across the care continuum will be positioned to move beyond point solutions toward integrated offerings that deliver measurable value. Conversely, organizations that omit interoperability, fail to address end-user experience, or neglect regional regulatory nuances may encounter adoption friction. Overall, the most successful players will be those that combine technical excellence with pragmatic implementation strategies, clear value propositions for providers and payers, and adaptable commercial models that reflect the diversity of clinical and homecare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dose Monitoring Device Market, by Type

  • 8.1. Non Wearable
  • 8.2. Wearable

9. Dose Monitoring Device Market, by Technology

  • 9.1. Bluetooth
  • 9.2. IoT Based
  • 9.3. Nfc
  • 9.4. Rfid

10. Dose Monitoring Device Market, by Application

  • 10.1. Cardiovascular Care
  • 10.2. Diabetes Management
  • 10.3. Oncology Treatment

11. Dose Monitoring Device Market, by End User

  • 11.1. Clinics
  • 11.2. Homecare Settings
  • 11.3. Hospitals

12. Dose Monitoring Device Market, by Distribution Channel

  • 12.1. Offline Channels
    • 12.1.1. Direct Sales
    • 12.1.2. Distributors
  • 12.2. Online Channels
    • 12.2.1. E Commerce Platforms
    • 12.2.2. Manufacturer Websites

13. Dose Monitoring Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Dose Monitoring Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Dose Monitoring Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Dose Monitoring Device Market

17. China Dose Monitoring Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Bayer AG
  • 18.6. Bracco S.p.A.
  • 18.7. Canon Inc.
  • 18.8. Dozee
  • 18.9. Fluke Corporation
  • 18.10. Fuji Electric Co., Ltd.
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. GE HealthCare Technologies, Inc.
  • 18.13. Guerbet
  • 18.14. IBA Dosimetry GmbH
  • 18.15. Infab Corporation
  • 18.16. INFINITT Healthcare Co., Ltd.
  • 18.17. Ion Beam Applications S.A.
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Landauer, Inc.
  • 18.20. LANDAUER, Inc. by Fortive Corporation
  • 18.21. Medic Vision
  • 18.22. Medsquare
  • 18.23. Mirion Technologies, Inc.
  • 18.24. Novarad Corporation
  • 18.25. PACSHealth, LLC
  • 18.26. PTW-Freiburg GmbH
  • 18.27. QAELUM NV
  • 18.28. Radcal Corporation
  • 18.29. Radiation Monitoring Devices, Inc.
  • 18.30. RADOS Technology Oy
  • 18.31. RaySafe by Fluke Corporation
  • 18.32. Sectra AB
  • 18.33. Siemens Healthineers AG
  • 18.34. Thermo Fisher Scientific, Inc.
  • 18.35. Unfors RaySafe AB
  • 18.36. Victoreen, LLC
  • 18.37. Volpara Health Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DOSE MONITORING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DOSE MONITORING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. GCC DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. NATO DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)